Experts speak on tackling COVID-19

Coronavirus and diabetes | Can DPP-4 inhibitors play a role?

Prof. Vijayam Balaji (left) and Prof. V. Seshiah.  

The whole world has been shaken by the COVID-19 pandemic. Scientists working in different fields such as epidemiology, virology and immunology are struggling to find the remedy to control and prevent this epidemic. A number of theories are going around about the cause and effect of this virus on human beings. The protective role of small pox and BCG vaccination from COVID-19 is also being analysed.

Morbidity and mortality due to COVID-19 is high in those with co-morbid conditions including Diabetes.

Type 2 diabetes is associated with low grade chronic inflammation induced by the excessive visceral adipose tissue (belly fat). Persistent hyperglycemia ( high blood sugar ) and inflammation can cause ineffective immune response resulting in decreased defense mechanism against any infection.

As a consequence, uncontrolled diabetes along with advanced age is a major factor of poor outcome during an infection with COVID-19.

Recently a ray of hope has appeared in the usefulness of the class of drug, DPP-4 inhibitors. DPP-4 inhibitors are used to control blood sugar levels and widely used in the treatment of Type 2 Diabetes.

We need to know the function of DPP-4 to understand the role of DPP-4 inhibitor. DPP-4 is a type 2 transmembrane glycoprotein expressed in many tissues including immune cells. Although its functions are not fully understood, it plays a role in post meal glucose regulation.

DPP-4 expression is high in visceral adipose tissues and increases inflammation and insulin resistance.

In a simple way we can now understand a drug that inhibits DPP-4 will reduce blood sugar, reduce insulin resistance and reduce inflammation.

Coming to COVID-19, excessive inflammatory response after an infection has been shown to be the major cause of an adverse outcome including acute respiratory distress syndrome and acute kidney injury. So harnessing the protective role of DPP-4 inhibitor in decreasing the profound inflammation seems logical.

Few studies published on the anti–inflammatory protective role of DPP-4 inhibitors in diabetic mice with MERS –CoV infection support this concept. A meta analysis in human beings also showed that upper respiratory tract infection does not increase significantly with DPP-4 inhibitors treatment.

It concluded that DPP-4 inhibitors have been associated with anti inflammatory and anti adipogenic effect.

We need more data on the anti-inflammatory effect of DPP-4 inhibitors in minimising the risk and the progression of acute respiratory complications in COVID-19 patients with Type 2 Diabetes.

Our code of editorial values

This article is closed for comments.
Please Email the Editor

Printable version | Jun 21, 2021 4:13:29 PM |

In This Series
Dr. Rahul Yadav on COVID-19 in neonates and infants
Non-COVID-19 emergencies in pandemic times
The role of palliative care
Lessons to follow after lockdown
Coronavirus | Does SARS-CoV-2 affect the liver?
Judiciously managing brain tumour patients
Don’t ignore abdominal symptoms
It’s important to protect skin
Private sector and patient safety
COVID-19: The tests reveal all
Will Vitamin C be of any help?
COVID-19 and the nervous system
You are reading
Coronavirus and diabetes | Can DPP-4 inhibitors play a role?
Masks are mandatory for all now
Stroke is an exception, rush to hospital
COVID-19 enhances reliance on telemedicine
‘How I fought COVID-19 and won!’
Coronavirus | What is convalescent plasma therapy?
Palliative care is the answer
Testing strategies for the virus
COVID-19: Breathing hard
Some tips to avoid diabetic amputations during lockdown
The virus versus women
Retaining the humanitarian approach in times of COVID-19
Do not ignore non-COVID-19 medical emergencies
In search of Vitamin D this summer of lockdown
Be alert, not anxious
Postponing elective surgeries can save lives
Sensitising parents of children with special needs
Aches and pains and a spot of exercise during COVID-19
Coronavirus | Managing pregnancy and childbirth
Coronavirus | Step up checking virus in patients, says virologist Jacob John
Boosting immunity is need of the hour
A look into key aspects of virus pandemic
COVID-19’s gut connection
Fighting a virus with dedicated health cadre
COVID-19 | Will it be polite with children?
Lessons from a pandemic: It’s OK to be smart
Does COVID-19 have a link with the eyes?
Sleepless during a pandemic: Insomnia going viral
Because the mind matters
Coronavirus | Are diabetics more prone to COVID-19?
What does COVID-19 mean for kidneys?
Next Story